Here are four micro-stories showcasing how our clients are safely and effectively unlocking value from structured and unstructured data.
Here are seven micro-stories showcasing how our clients are safely and effectively unlocking value from structured and unstructured data.
Privacy Analytics’ Redaction-as-a-Service ensures fast, cost-effective clinical trial document submissions at scale Reduces submission time from weeks to days using proprietary Mirage software – ...
We believe that data-driven insights are critical to addressing challenges introduced by the current pandemic, and that benefits can be realized while respecting privacy. What are the challenges ...
I wrote in our September newsletter about how trial sponsors are well advised to view transparency as much more than just a box that has to be checked off. This time, I would like to dig deeper into ...
Pharmaceutical companies today are well-advised to view transparency as an opportunity to enhance their reputation in the marketplace and earn trust with stakeholders, which can ultimately benefit ...
Just over a year ago, Health Canada stipulated that all clinical trials documents needed to make their way onto its designated portal. And, like those entering a portal in popular fiction, everyone ...
Privacy Analytics is wholly committed to the global effort to respond to COVID-19. We have the collective will, the personal urgency and the technical ability to make a meaningful difference in the ...
I recently heard something that stuck with me: “Nobody complies their way to greatness.” An interesting comment, and a relevant one for all of us in the clinical trial transparency domain. But is ...
Should sponsors integrate risk-based anonymization across both documents and structured individual patient data (S-IPD)?
Unstructured data, such as medical notes, pose unique challenges with regards to anonymization. Not having a traditional database means that you can’t point a software solution to it to transform ...
Health Canada has introduced new regulatory guidance for anonymizing clinical study reports. As background, Bill C-17 Protecting Canadians from Unsafe Drugs Act (Vanessa’s Law) was initiated to ...
Event: Privacy Analytics’ Executive Round Table on the Future of Clinical Trials Data Sharing, September 18, 2018, London, England This invitation-only event was adjacent to the London DIA Global ...
If your organization is focused on maximizing data value, while also protecting data as a core asset, you may be on the horns of a privacy dilemma. Why? As an analytics leader or Chief Data Officer, ...
Privacy Analytics is pleased to partner with Vivli: a new, groundbreaking digital platform where researchers can request and analyze clinical trial data sets in a secure research environment.
Filter by Data Type
Categories
